Management of Anticoagulation and Hemostasis for Pediatric Extracorporeal Membrane Oxygenation
- 1 September 2014
- journal article
- review article
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 34 (3) , 655-673
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Antifibrinolytic agents in current anaesthetic practiceBritish Journal of Anaesthesia, 2013
- Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenationPerfusion, 2012
- Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenationCritical Care, 2011
- Plasma Restoration of Endothelial Glycocalyx in a Rodent Model of Hemorrhagic ShockAnesthesia & Analgesia, 2011
- Anticoagulation in neonates and children: Pitfalls and dilemmasBlood Reviews, 2010
- Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparinThrombosis and Haemostasis, 2010
- Very high users of platelet transfusions in the neonatal intensive care unitTransfusion, 2009
- Argatroban in Extracorporeal Membrane OxygenationArtificial Organs, 2007
- Anticoagulation and Pediatric Extracorporeal Membrane Oxygenation: Impact of Activated Clotting Time and Heparin Dose on SurvivalThe Annals of Thoracic Surgery, 2007
- Assessing Heparin Dosing in Neonates on Venoarterial Extracorporeal Membrane OxygenationASAIO Journal, 2007